Tom Albright, the chairman and CEO of Andrew Technologies, has over 3 decades of experience in pharmaceutical, biological, and device industries and has had a great involvement with and knowledge of aesthetic sales, marketing and management.
He has worked with such distinguished healthcare and medical companies such as Parke-David division of Warner Lambert Company, Allergan, Nobel Biocare and GlaxoSmithkline.
Tom has led the successful marketing launches of Lipotor® and several other leading brands; He is also responsible for heading the global commercial development of Latisse® and leading the highly successful worldwide launch of Botox®.
He is an avid visiting lecturer at leading MBA programs and has actively participated as a speaker and panel member at numerous industry events.
Tom received his B.S in biology from The Citadel and earned an MBA in marketing from Mercer University.